Terms: = Brain cancer AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790 AND Treatment
5 results:
1. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
2. Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer.
Lee KS; Lee CK; Kwon SS; Kwon WS; Park S; Lee ST; Choi JR; Rha SY; Shin S
Clin Chem Lab Med; 2024 Jan; 62(1):178-186. PubMed ID: 37435889
[TBL] [Abstract] [Full Text] [Related]
3. Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior.
Szabó B; Németh K; Mészáros K; Szücs N; Czirják S; Reiniger L; Rajnai H; Krencz I; Karászi K; Krokker L; Patócs A; Butz H
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32232382
[TBL] [Abstract] [Full Text] [Related]
4. Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma.
Fukunaga T; Fujita Y; Kishima H; Yamashita T
PLoS One; 2018; 13(11):e0206552. PubMed ID: 30388142
[TBL] [Abstract] [Full Text] [Related]
5. Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling.
M Gagné L; Boulay K; Topisirovic I; Huot MÉ; Mallette FA
Trends Cell Biol; 2017 Oct; 27(10):738-752. PubMed ID: 28711227
[TBL] [Abstract] [Full Text] [Related]
